Pilot Study of BCAA on Sleep
Key facts
- Who runs it
- Portland VA Medical Center
- Where
- Portland, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 1 Mar 2019
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Branched Chain Amino Acids
- Rice Protein
- Microcrystalline Cellulose
- Record updated
- 17 September 2026
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Veteran
- English Speaking
- Accessible via phone
- Sleep problems
Who cannot take part
- Currently taking BCAAs
- Decisional impairment
- Nickel allergy
- Maple syrup urine disease or family history of disease
- Allergy to sucralose
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sleep disorder or traumatic brain injury
This trial is currently available in United States.
- VA Portland Health Care SystemPortland, United StatesContact: Miranda M Lim, MD, PhDTaking people
About the trial
What the trial wants to find out
Individuals will be recruited from the VA Portland Health Care System and the community affiliated with Oregon Health \& Science University. Traumatic brain injury status will be assessed as a contributing factor. Subjects will be randomized to one of 3 groups (BCAA or one of 2 placebo conditions) and instructed to consume study product twice daily for 21 days. Self-report questionnaires, wrist actigraphy, pressure pain testing, and cognitive function will be assessed pre and post the experimental period.
The 3 groups in the trial
- BCAAsTreatment being tested
60 grams of BCAA (2:1:1 ratio of Leucine:Isoleucine:Valine) consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21 days (42 total drinks).
Treatment: Branched Chain Amino Acids
- Rice ProteinPlacebo, for comparison
Rice protein control group: 60 grams of rice protein consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21 days (42 total drinks).
- Microcrystalline CellulosePlacebo, for comparison
Placebo control group: 60 grams of microcrystalline cellulose, consumed in two doses (30 grams each) mixed into 20 oz of water for up to 21 days (42 total drinks).
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pilot Study of Dietary Supplementation With Branched Chain Amino Acids on Sleep
- Criteria questions
- Built from NCT03990909, who can take part
- Publications
- Record updated
- 17 September 2026